Xue Jun Wang
Plus aucun poste en cours
Profil
Xue Jun Wang served as the Chief Executive Officer & Executive Director at China Regenerative Medicine International Ltd.
from 2018 to 2020.
Prior to that, he held positions as Director & General Manager at Heze Biotechnology Co. Ltd., General Manager-Marketing Centre at Union Stem Cell & Gene Engineering Co., Ltd., and Executive Deputy General Manager at Vcanbio Cell & Gene Engineering Corp.
Mr. Wang earned an MBA from Nankai University.
Anciens postes connus de Xue Jun Wang
| Sociétés | Poste | Fin |
|---|---|---|
| CHINA REGENERATIVE MEDICINE INTERNATIONAL LIMITED | Directeur Général | 09/07/2020 |
Heze Biotechnology Co. Ltd.
 Heze Biotechnology Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Vcanbio Cell & Gene Engineering Corp., Ltd., Heze Biotechnology Co. Ltd. engages in the research and development of stem cell and related biological agents. The company is based in Beijing, China. Heze Biotechnology Co. was acquired by Vcanbio Cell & Gene Engineering Corp., Ltd. from Tianjin Tengzhou Life Science & Technology Investment Co. Ltd on March 22, 2012 for $7.40 million. | Directeur/Membre du Conseil | - |
Union Stem Cell & Gene Engineering Co., Ltd.
 Union Stem Cell & Gene Engineering Co., Ltd. BiotechnologyHealth Technology Union Stem Cell & Gene Engineering Co., Ltd. engages in the development of stem cell therapeutic products. Its business activities include stem cell resource conservation, stem cell clinical transplant, and research and development of monoclonal antibodies treatment and gene chip. The company was founded on February 16, 2001 and is headquartered in Tianjin, China. | Corporate Officer/Principal | - |
Vcanbio Cell & Gene Engineering Corp.
 Vcanbio Cell & Gene Engineering Corp. Miscellaneous Commercial ServicesCommercial Services Vcanbio Cell & Gene Engineering Corp. develops and stores cord blood hematopoietic stem cells. | Corporate Officer/Principal | - |
Formation de Xue Jun Wang
| Nankai University | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CHINA REGENERATIVE MEDICINE INTERNATIONAL LIMITED | Health Technology |
| Entreprise privées | 3 |
|---|---|
Union Stem Cell & Gene Engineering Co., Ltd.
Union Stem Cell & Gene Engineering Co., Ltd. BiotechnologyHealth Technology Union Stem Cell & Gene Engineering Co., Ltd. engages in the development of stem cell therapeutic products. Its business activities include stem cell resource conservation, stem cell clinical transplant, and research and development of monoclonal antibodies treatment and gene chip. The company was founded on February 16, 2001 and is headquartered in Tianjin, China. | Health Technology |
Heze Biotechnology Co. Ltd.
Heze Biotechnology Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Vcanbio Cell & Gene Engineering Corp., Ltd., Heze Biotechnology Co. Ltd. engages in the research and development of stem cell and related biological agents. The company is based in Beijing, China. Heze Biotechnology Co. was acquired by Vcanbio Cell & Gene Engineering Corp., Ltd. from Tianjin Tengzhou Life Science & Technology Investment Co. Ltd on March 22, 2012 for $7.40 million. | Commercial Services |
Vcanbio Cell & Gene Engineering Corp.
Vcanbio Cell & Gene Engineering Corp. Miscellaneous Commercial ServicesCommercial Services Vcanbio Cell & Gene Engineering Corp. develops and stores cord blood hematopoietic stem cells. | Commercial Services |
